Medical Oncology Hematology Consultants, P.A. — Newark, Delaware

Medical Oncology Hematology Consultants, P.A. is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Medical Oncology Hematology Consultants, P.A. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor.

Sponsors: Relay Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newark

Browse all research sites in Delaware · View every site in Newark

• University of Delaware, Energy Balance and Nutrition Laboratory
• University of Delaware, Physical Therapy Department
• Christiana Hospital Helen F. Graham Cancer Center
• Health Sciences Campus, University of Delaware
• Chrisitana Care Health System-Christiana Hospital
• University of Delaware College of Health Sciences
• Christiana Hospital - Special Care Nursery
• Christiana Hospital, Christiana Care Health Services
• University of Delaware: Infant Motor Beahvior Lab
• Department of Kinesiology and Applied Physiology, University of Delaware
• Christiana Hospital, Department of Emergency Medicine
• 8401134 - Christiana Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical Oncology Hematology Consultants, P.A.?

Medical Oncology Hematology Consultants, P.A. has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical Oncology Hematology Consultants, P.A. conducted?

Medical Oncology Hematology Consultants, P.A. has 1 clinical trials on record, with 1 currently active. Their work covers PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor.

Is Medical Oncology Hematology Consultants, P.A. accredited by Crixeo Clinical Trials?

Medical Oncology Hematology Consultants, P.A. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical Oncology Hematology Consultants, P.A.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.